• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat.

作者信息

Nelson S D, Mitchell J R, Timbrell J A, Snodgrass W R, Corcoran G B

出版信息

Science. 1976 Sep 3;193(4256):901-3. doi: 10.1126/science.7838.

DOI:10.1126/science.7838
PMID:7838
Abstract

Acetylhydrazine, a metabolite of isoniazid, a widely used antituberculosis drug, and isopropylhydrazine, a metabolite of iproniazid, an antidepressant removed from clinical use because of high incidence of liver injury, were oxidized by cytochrome P-450 enzymes in human and rat liver microsomes to highly reactive acylating and alkylating agents. Covalent binding of these metabolites to liver macromolecules paralleled hepatic cellular necrosis. The metabolites formed from these and probably other monosubstituted hydrazines are reactive electrophiles.

摘要

相似文献

1
Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat.
Science. 1976 Sep 3;193(4256):901-3. doi: 10.1126/science.7838.
2
Hepatotoxicity and metabolism of iproniazid and isopropylhydrazine.异烟酰异丙肼和异丙肼的肝毒性及代谢
J Pharmacol Exp Ther. 1978 Sep;206(3):574-85.
3
The role of metabolism in the hepatotoxicity of isoniazid and iproniazid.
Drug Metab Rev. 1979;10(1):125-47. doi: 10.3109/03602537908993904.
4
Studies on the role of acetylhydrazine in isoniazid hepatotoxicity.
Arch Toxicol Suppl. 1979(2):1-8. doi: 10.1007/978-3-642-67265-1_1.
5
Spin trapping of free radical intermediates produced during the metabolism of isoniazid and iproniazid in isolated hepatocytes.在分离的肝细胞中异烟肼和异丙烟肼代谢过程中产生的自由基中间体的自旋捕获。
Biochem Pharmacol. 1987 Sep 15;36(18):2913-20. doi: 10.1016/0006-2952(87)90202-4.
6
Isoniazid hepatoxicity: the relationship between covalent binding and metabolism in vivo.异烟肼肝毒性:体内共价结合与代谢之间的关系。
J Pharmacol Exp Ther. 1980 May;213(2):364-9.
7
Propane and propylene formation during the microsomal metabolism of iproniazid and isopropylhydrazine.
Life Sci. 1985 Mar 11;36(10):947-54. doi: 10.1016/0024-3205(85)90390-x.
8
The role of biotransformation in chemical-induced liver injury.生物转化在化学性肝损伤中的作用。
Environ Health Perspect. 1976 Jun;15:27-38. doi: 10.1289/ehp.761527.
9
Cimetidine inhibits the formation of the reactive, toxic metabolite of isoniazid in rats but not in man.
Hepatology. 1985 Jul-Aug;5(4):607-9. doi: 10.1002/hep.1840050414.
10
Studies on the effects of isoniazid on acetylhydrazine metabolism in vivo and in vitro.
Drug Metab Dispos. 1979 Jul-Aug;7(4):237-40.

引用本文的文献

1
Deploying the drug repurposing approach for the identification of selective monoamine oxidase-B inhibitors against neurological disabilities: an in Silico and in vitro approach.采用药物重新利用方法鉴定针对神经功能障碍的选择性单胺氧化酶-B抑制剂:一种计算机模拟和体外实验方法。
J Comput Aided Mol Des. 2025 Aug 29;39(1):71. doi: 10.1007/s10822-025-00652-x.
2
Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement.异烟肼——历史发展、代谢相关毒性及其药理学改进展望
Front Pharmacol. 2024 Sep 19;15:1441147. doi: 10.3389/fphar.2024.1441147. eCollection 2024.
3
Another Step Closer to Genomic-informed Therapeutic Dosing for Tuberculosis Drugs.
结核病药物基因组学指导治疗剂量又迈进了一步。
Am J Respir Crit Care Med. 2024 Jun 15;209(12):1427-1428. doi: 10.1164/rccm.202403-0566ED.
4
A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing.基于纳米孔测序的个体化结核病药物剂量调整的药物基因组学检测 panel。
Am J Respir Crit Care Med. 2024 Jun 15;209(12):1486-1496. doi: 10.1164/rccm.202309-1583OC.
5
Metabolic bioactivation of antidepressants: advance and underlying hepatotoxicity.抗抑郁药的代谢生物活化:进展与潜在肝毒性。
Drug Metab Rev. 2024 Feb-May;56(2):97-126. doi: 10.1080/03602532.2024.2313967. Epub 2024 Feb 20.
6
A blinded in vitro analysis of the intrinsic immunogenicity of hepatotoxic drugs: implications for preclinical risk assessment.一种对肝毒性药物固有免疫原性的盲法体外分析:对临床前风险评估的影响。
Toxicol Sci. 2023 Dec 21;197(1):38-52. doi: 10.1093/toxsci/kfad101.
7
Study on the associations between liver damage and antituberculosis drug rifampicin and relative metabolic enzyme gene polymorphisms.抗结核药利福平致肝损伤与相关代谢酶基因多态性的相关性研究。
Bioengineered. 2021 Dec;12(2):11700-11708. doi: 10.1080/21655979.2021.2003930.
8
Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid.异烟腙化是一种组蛋白标记,由抗结核一线药物异烟肼诱导产生。
Nat Commun. 2021 Sep 20;12(1):5548. doi: 10.1038/s41467-021-25867-y.
9
Cell Type-Specific Roles of CD38 in the Interactions of Isoniazid with NAD in the Liver.细胞类型特异性 CD38 在异烟肼与 NAD 在肝脏相互作用中的作用。
Drug Metab Dispos. 2020 Dec;48(12):1372-1379. doi: 10.1124/dmd.120.000139. Epub 2020 Oct 5.
10
Determination of isoniazid acetylation patterns in tuberculosis patients receiving DOT therapy under the Revised National tuberculosis Control Program (RNTCP) in India.在印度修订后的国家结核病控制规划(RNTCP)下,对接受直接观察治疗(DOT)的结核病患者的异烟肼乙酰化模式进行测定。
Saudi Pharm J. 2020 Jun;28(6):641-647. doi: 10.1016/j.jsps.2020.04.003. Epub 2020 Apr 19.